JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer

Podcast: Journal of Clinical Oncology (JCO) Podcast · American Society of Clinical Oncology (ASCO)

Opublikowano: 2026-04-27

Host Jake New summarizes and offers insights into the JCO article by Licitra et al., "Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study." LINK TO FULL TRANSCRIPT